Basing a supplement business on clinical science can be a costly and highrisk positioning strategy but one that could also pay off handsomely in the long term. Endomatrix Inc. is a venture capital backed company positioned biotech-style upon a platform of vascular endothelial function rather than a particular product.
The platform places the company at the front-end of the disease process, since better endothelial health can help reduce the inflammation associated wi
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.